How big is the South Korea Oral Anti-Diabetic Drug Market?

The South Korea Oral Anti-Diabetic Drug Market size is expected to reach USD 0.95 billion in 2024 and grow at a CAGR of 3.80% to reach USD 1.14 billion by 2029. Read More

What is the current South Korea Oral Anti-Diabetic Drug Market size?

In 2024, the South Korea Oral Anti-Diabetic Drug Market size is expected to reach USD 0.95 billion. Read More

Who are the key players in South Korea Oral Anti-Diabetic Drug Market?

Eli Lilly and Company, Astellas, Sanofi, Janseen and Astrazeneca are the major companies operating in the South Korea Oral Anti-Diabetic Drug Market. Read More

What years does this South Korea Oral Anti-Diabetic Drug Market cover, and what was the market size in 2023?

In 2023, the South Korea Oral Anti-Diabetic Drug Market size was estimated at USD 0.91 billion. The report covers the South Korea Oral Anti-Diabetic Drug Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the South Korea Oral Anti-Diabetic Drug Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

South Korea Oral Anti-Diabetic Drug Market Share

Statistics for the 2023 & 2024 South Korea Oral Anti-Diabetic Drug market share, created by Mordor Intelligence™ Industry Reports. South Korea Oral Anti-Diabetic Drug share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of South Korea Oral Anti-Diabetic Drug Industry

The South Korean oral anti-diabetes drug market is consolidated, with a few major manufacturers like Eli Lilly, AstraZeneca, Sanofi, and Janssen Pharmaceuticals having a global market presence, while the remaining manufacturers are confined to the other local or regional markets. Companies are focusing on innovations in diabetes drugs.